NCT01280240View on ClinicalTrials.gov

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

November 30, 2012

Conditions
Patients With Chemotherapy Induced Anemia (CIA)
Interventions
DRUG

Monofer(R)

Intravenous bolus injection given over app. 2 minutes only once

Trial Locations (2)

21237

Baltimore, MD

Unknown

Gabrail Cancer Center, Canton

Sponsors

Lead Sponsor

Pharmacosmos A/S
All Listed Sponsors
lead

Pharmacosmos A/S

INDUSTRY